Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b40f57b2932d297f77061528049ce28a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd136ec21e61bab01f0780f7a0a55ee9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T156-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B32B37-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2011-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_981461e0d554787ebcd68186937feac9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b87ea7b27e78951a861e0421abc8355c |
publicationDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013011449-A1 |
titleOfInvention |
Solid preparation |
abstract |
The present invention relates to a solid preparation having an easily controllable elution property of a drug, and a method for improving dissolution of a drug. n A solid preparation 1 comprises a drug-containing unit 2 containing a drug, a gel-forming layer 4 for covering the drug-containing unit 2 and forming a gel by water absorption, and an intermediate layer 3 interposed between the drug-containing unit 2 and the gel-forming layer 4. The elution property of the drug is improved by forming a plurality of pores extending from a surface of the gel-forming layer toward the intermediate layer in the gel-forming layer 4 . The gel-forming layer 4 may be covered with an anti-adhesive layer 5 . The anti-adhesive layer 5 may have a pore 6 extending from a surface thereof and communicating with the pore of the gel-forming layer. The drug-containing unit 2 may contain a cationic or basic drug. The gel-forming layer 4 may contain an anionic or acidic polymer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229582-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017237534-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654090-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026868-B2 |
priorityDate |
2010-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |